Vident Advisory’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$352K Sell
3,482
-160
-4% -$16.6K ﹤0.01% 1545
2026
Q1
$352K Buy
3,642
+1,163
+47% +$119K ﹤0.01% 1423
2025
Q4
$263K Sell
2,479
-255
-9% -$29.6K ﹤0.01% 1427
2025
Q3
$347K Sell
2,734
-6
-0.2% -$714 ﹤0.01% 1337
2025
Q2
$336K Buy
+2,740
New +$313K ﹤0.01% 1251

Other funds holding EHC

Vident Advisory's EHC Position: Q2 2026 in Review

Vident Advisory reduced its Encompass Health (EHC) stake by 4.4% in Q2 2026, selling an estimated $16.6K and leaving 3,482 shares worth $352K. The position accounts for ﹤0.01% of the portfolio, ranked #1545.

Vident Advisory first reported a position in EHC in Q2 2025 and has held it in 5 quarters since. The position peaked at $352K in Q1 2026. 597 funds tracked by Wall St. Rank hold EHC as of Q2 2026.

  • Vident Advisory held 3,482 shares of Encompass Health worth $352K as of Q2 2026.
  • Vident Advisory sold 160 Encompass Health shares in Q2 2026, an estimated $16.6K.
  • Encompass Health made up ﹤0.01% of Vident Advisory's portfolio in Q2 2026, its #1545 holding.
  • Vident Advisory first reported a position in Encompass Health in Q2 2025 and has held it in 5 quarters since.
  • Vident Advisory's Encompass Health position peaked at $352K in Q1 2026.
  • 597 funds tracked by Wall St. Rank held Encompass Health as of Q2 2026.

Based on Vident Advisory's 13F filing for Q2 2026, filed 12 Aug 2026.